Cyclacel Pharmaceuticals, Inc. (BGMS)
Market Closed
16 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 82
-0.01
-1.2048%
$
1.96M Market Cap
- P/E Ratio
- Div Yield
109,378 Volume
- Eps
$ 0.83
Previous Close Want to track BGMS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cyclacel Pharmaceuticals, Inc. (BGMS) Statistics
Valuation metrics
Market Cap 1.96M
Enterprise value -1.63M
Trailing P/E (ttm) -1.37
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 1.12
Price/Book (mrq) 0.63
Enterprise Value/Revenue -1.07
Enterprise Value/EBITDA 0.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 14.47M
Average volume (90 days) 1.92M
Price summary
52-Week low 0.73
52-Week high 19.87
Beta -
50-Day moving average 0.99
200-Day moving average 1.14
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.03
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 7 Jul 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.04%
Operating margin -2.38%
Operational effectiveness
Return on assets -0.41%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.28
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.61
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.06%
Book value per share (mrq) 1.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
